Skip to content

Study · Measured the body's own peptide · 2013

1 result

MALDI imaging of post-mortem human spinal cord in amyotrophic lateral sclerosis.

Hanrieder J, Ekegren T, Andersson M, Bergquist J

Journal of neurochemistry28 Jan 2013Cited by 41 (Europe PMC)

PMID22994484 (opens in a new tab)DOI10.1111/jnc.12019 (opens in a new tab)PepBankPUB-22994484
Source linkPubMedAsk about this study
Jump to 1 result

Summary

The text of this summary is not shown here, because the article license does not allow reuse. Read it at the source (opens in a new tab)

Text rights: Publisher copyright. Results still quote short attributed sentences.

Results from this study1

No result from this study comes from a test of the peptide.

Natural levels measured1

These results measure the body's own peptide. Nobody was given the peptide. They are not evidence about taking it. They are left out of key results, evidence counts and charts.

  1. 01HumanEndogenous levelObservational studyOther

    In normal post-mortem human spinal cord, MALDI imaging located thymosin beta‑4 mainly in the gray matter.

    In plain wordsIn normal human spinal cord samples, the body's own thymosin beta‑4 was found mainly in the gray matter.

    Peptide
    Thymosin beta-4 (human)
    Outcome
    Not applicableSpinal cord distribution of thymosin beta 4
    Study

    n: not reported in source

    Outcome group
    Endogenous peptide levels · Nervous system and cognition

    Source sentences

    Summary
    thymosin beta 4, ubiquitin, histone proteins, acyl-CoA-binding protein, and macrophage inhibitory factor were predominantly localized to the gray matter.
    1 context sentence
    Summary · context
    In this study, we report for the first time the MALDI imaging-based spatial protein profiling and relative quantification of post-mortem human spinal cord samples obtained from ALS patients and controls.

    This result measures the body's own Thymosin beta-4 (human). Nobody was given the peptide. It is not evidence about taking it.

AI wrote and checked these results. AI can make mistakes, so check important results against the source.

Version history

PepBank keeps every version of the data on this study. Status changes from Retraction Watch, Europe PMC and Crossref are listed with their source.

  1. Version 2Current

    13 Oct 2026, 01:52 UTC

    Study results updated

  2. Version 1

    12 Oct 2026, 18:17 UTC

    First added · source update from Europe PMC

Subjects

Terms as the source lists them.

PepBank is a research reference. Talk to a doctor before you use any peptide.